Literature DB >> 9292567

Rats with moderate renal failure show capillary deficit in heart but not skeletal muscle.

K Amann1, K A Neimeier, U Schwarz, J Törnig, S Matthias, S R Orth, G Mall, E Ritz.   

Abstract

In previous studies on experimental renal failure, hypertrophy of cardiomyocytes, diminished capillarization, and increased intercapillary distances had been observed, abnormalities that will expose the heart to reduced ischemia tolerance. It has not been established, however, whether such structural alterations are unique for the heart (eg, as a consequence of left ventricular hypertrophy) or are demonstrable in other tissues as well. Clarification of this point is important to test hypotheses on some potential mechanisms for cardiac undercapillarization. To address this issue further, we compared capillary length density (by stereologic techniques) in perfusion-fixed skeletal muscle (m. psoas) and hearts of subtotally nephrectomized (SNX) rats with moderate renal failure to those in sham-operated pair-fed controls. The duration of renal failure was 8 weeks. SNX rats had significantly higher mean systolic blood pressure (128 mm Hg v 109 mm Hg), serum creatinine, and urea levels. Despite pair feeding, the mean body weight was significantly lower in the SNX rats (409 g v 471 g), but the left ventricular weight to body weight ratio tended to be higher than in the sham-operated controls (2.39 mg/g v 2.13 mg/g). In the heart, myocyte mean cross-sectional area (675 +/- 112 microm2 v 545 +/- 111 microm2) and volume density of nonvascular interstitial tissue (3.47 +/- 1.04 v 1.33 +/- 0.22) were significantly higher in the SNX rats than in the controls. In parallel, myocardial capillary length density was significantly reduced after subtotal nephrectomy (3,036 +/- 535 mm/mm3 v 3,916 +/- 615 mm/mm3). In contrast, in skeletal muscle, myocyte cross-sectional area (3,109 +/- 783 microm2 v 3,042 +/- 639 microm2), capillary length density (718 +/- 248 mm/mm3 v 717 +/- 184 mm/mm3), and three-dimensional capillary fiber ratio (2.10 +/- 0.26 v 2.13 +/- 0.4) were similar in SNX and control rats. These data document a selective defect of capillarization in the heart of animals with moderate renal failure, pointing to tissue-specific abnormalities of cardiac capillarogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292567     DOI: 10.1016/s0272-6386(97)90283-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  11 in total

1.  Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease.

Authors:  David M Charytan; Robert Padera; Alexander M Helfand; Michael Zeisberg; Xingbo Xu; Xiaopeng Liu; Jonathan Himmelfarb; Angeles Cinelli; Raghu Kalluri; Elisabeth M Zeisberg
Journal:  Int J Cardiol       Date:  2014-07-06       Impact factor: 4.164

Review 2.  Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease.

Authors:  David Charytan
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

3.  CKD and coronary collateral supply in individuals undergoing coronary angiography after myocardial infarction.

Authors:  David M Charytan; Noam M Stern; Laura Mauri
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 8.237

4.  Identification of cardiovascular abnormalities by multiparametric magnetic resonance imaging in end-stage renal disease patients with preserved left ventricular ejection fraction.

Authors:  Ling Lin; Qiuxia Xie; Mei Zheng; Xuhui Zhou; Ilona A Dekkers; Qian Tao; Hildo J Lamb
Journal:  Eur Radiol       Date:  2021-02-24       Impact factor: 5.315

5.  High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy.

Authors:  Karin Tyralla; Marcin Adamczak; Kerstin Benz; Valentina Campean; Marie-Luise Gross; Karl F Hilgers; Eberhard Ritz; Kerstin Amann
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

6.  Experimental models of renal disease and the cardiovascular system.

Authors:  Rebecca C Grossman
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

7.  Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney Disease.

Authors:  Dorothea Burkhardt; Maria Bartosova; Betti Schaefer; Niels Grabe; Bernd Lahrmann; Hamoud Nasser; Christian Freise; Axel Schneider; Anja Lingnau; Petra Degenhardt; Bruno Ranchin; Peter Sallay; Rimante Cerkauskiene; Michal Malina; Gema Ariceta; Claus Peter Schmitt; Uwe Querfeld
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

Review 8.  Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease.

Authors:  Szu-Chun Hung; Ko-Lin Kuo; Chih-Cheng Wu; Der-Cherng Tarng
Journal:  J Am Heart Assoc       Date:  2017-02-07       Impact factor: 5.501

9.  Chronic kidney disease induces a systemic microangiopathy, tissue hypoxia and dysfunctional angiogenesis.

Authors:  Hans-Ulrich Prommer; Johannes Maurer; Karoline von Websky; Christian Freise; Kerstin Sommer; Hamoud Nasser; Rudi Samapati; Bettina Reglin; Pedro Guimarães; Axel Radlach Pries; Uwe Querfeld
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

10.  Gene expression profiling on global cDNA arrays gives hints concerning potential signal transduction pathways involved in cardiac fibrosis of renal failure.

Authors:  Kerstin Amann; Heidrun Ridinger; Christiane Rutenberg; Eberhard Ritz; Gerhard Mall; Christian Maercker
Journal:  Comp Funct Genomics       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.